Richard Scott Struthers - 07 Sep 2021 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
07 Sep 2021
Net transactions value
-$750,000
Form type
4
Filing time
09 Sep 2021, 17:00:31 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common stock Sale $250,000 -10,000 -10% $25.00 90,000 07 Sep 2021 By Family Trust 2 F1
transaction CRNX Common stock Sale $250,000 -10,000 -10% $25.00 90,000 07 Sep 2021 By Family Trust 3 F1
transaction CRNX Common stock Sale $250,000 -10,000 -10% $25.00 90,000 07 Sep 2021 By Family Trust 4 F1
holding CRNX Common stock 1,000 07 Sep 2021 By Spouse
holding CRNX Common stock 4,000 07 Sep 2021 Direct
holding CRNX Common stock 890,805 07 Sep 2021 By Family Trust 1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.